Posted in | News | Quantum Optics

Oxford Instruments NanoScience Delivers First Proteox Globally to Oxford Quantum Circuits

Today, Oxford Instruments NanoScience, the pioneers in dilution refrigerator technology, announces its partnership with Oxford Quantum Circuits (OQC), to accelerate quantum computing commercialization in the UK. As part of the collaboration, OQC is taking delivery of Oxford Instruments’ next-generation Cryofree® refrigerator, Proteox.

Proteox was specifically designed to facilitate high-density wiring with insert-modulatory. OQC will leverage these features to enhance the scaling of its unique 3D architecture, also paving the way towards quantum-focused Measurements as a Service capability. OQC is the first company worldwide to take delivery of the Proteox.

Our collaboration with Oxford Instruments NanoScience and our work with Proteox is a significant milestone in our plans to build a quantum-powered future. Proteox will complement our equipment capability in our new state-of-the-art laboratory, further enabling our customers to access our technology online and on-site.

Ilana Wisby, CEO, OQC 

The technology OQC is developing is at the leading edge of quantum computing and will assist in trailblazing new approaches today, including discovering new medical treatments and solving some of humanity’s greatest problems such as combating climate change. 

This announcement demonstrates how Oxford Instruments is ensuring that the innovators in quantum computing like OQC have access to the best platform for the development of next-generation quantum technologies, from early-stage single qubit research, right through to commercial quantum computer scale-up, opening up new territories for quantum commercialization today – not tomorrow. This is great news for the UK’s quantum push.

Stuart Woods, Managing Director, Oxford Instruments NanoScience

Proteox is a next-generation Cryofree system that provides a step-change in modularity and adaptability for ultra-low temperature experiments in condensed-matter physics and quantum computing industrialization. The Proteox platform has been developed to provide a single, interchangeable modular solution that can support multiple users and a variety of set-ups or experiments while also enabling remote management. To find out more, visit nanoscience.oxinst.com/proteox.
 

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Oxford Instruments Nanoscience. (2021, January 07). Oxford Instruments NanoScience Delivers First Proteox Globally to Oxford Quantum Circuits. AZoQuantum. Retrieved on November 21, 2024 from https://www.azoquantum.com/News.aspx?newsID=7677.

  • MLA

    Oxford Instruments Nanoscience. "Oxford Instruments NanoScience Delivers First Proteox Globally to Oxford Quantum Circuits". AZoQuantum. 21 November 2024. <https://www.azoquantum.com/News.aspx?newsID=7677>.

  • Chicago

    Oxford Instruments Nanoscience. "Oxford Instruments NanoScience Delivers First Proteox Globally to Oxford Quantum Circuits". AZoQuantum. https://www.azoquantum.com/News.aspx?newsID=7677. (accessed November 21, 2024).

  • Harvard

    Oxford Instruments Nanoscience. 2021. Oxford Instruments NanoScience Delivers First Proteox Globally to Oxford Quantum Circuits. AZoQuantum, viewed 21 November 2024, https://www.azoquantum.com/News.aspx?newsID=7677.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.